Find your path to Marianne
1,900 people in our graph share verified history with Marianne — schools, employers, funds. One of them is your warm intro.
Deep NisharunlockedMarianne: together at Gladstone Institutes (2021–2026)
×6Marianne: together at Harvard Business School
Marianne: together at Johnson & Johnson
Marianne: together at INSEAD
CEO at Vir
Intro paths
→
In turn, Marianne can intro founders to Vir's investors below.
Experience
- Vir Biotechnology, Inc.CEO and Presidentcurrent2026 — presentNorth America
- Vir Biotechnology, Inc.Chief Executive Officercurrent2023 — presentUnited States
- Biotechnology Innovation OrganizationBoard Membercurrent2024 — present
- Ghent UniversityFounding Board Member University Ghent alumni / Chapter USA Westcurrent2021 — present
- Gladstone InstitutesMember Board Of Directors, Gladstone Foundationcurrent2017 — presentSan Francisco, California
- Kronos Bio, Inc.Member Board Of Directors2021 — 2023San Mateo, California, United States
- Arrowhead PharmaceuticalsMember Board of Directors2019 — 2023Pasadena, California
- BayerMember of the Executive Committee, EVP, Global Head Strategy, BD&L and Open Innovation (CBO)2020 — 2023Berlin, Germany
- BayerMember of the Executive Committee, EVP, Global Head Strategy and Business Development (CBO)2019 — 2020Berkeley, California
- BlueRock TherapeuticsMember Board Of Directors2022 — 2023Cambridge, Massachusetts, United States
- Vividion Therapeutics. Inc.Vice-Chair Board of Directors (a Bayer company)2021 — 2023San Diego, California, United States
- Asklepios BioPharmaceutical, Inc. (AskBio)Member Board Of Directors (a Bayer company)2020 — 2023North Carolina, United States
- EcoHealth AllianceMember, Board Of Directors Ecohealth Alliance (non for profit)2017 — 2021New York
- BiocomAdvisory Board Member2018 — 2020San Francisco Bay Area
- Johnson & JohnsonGlobal Vice President, M&A Ops, Divestitures and IDV BD2018 — 2019South San Francisco
- San Jose State UniversityInstructor Business & Finance Perspectives of the Biotechnology Industry2018San Jose, California
- Johnson & JohnsonVice President, Venture Investments, JJDC2017 — 2018San Francisco Bay Area
- Johnson & JohnsonVice President, Johnson & Johnson Innovation - Janssen Business Development2013 — 2016San Francisco, United States and Beerse, Belgium
- The Janssen Pharmaceutical Companies of Johnson & JohnsonBUSINESS UNIT LEADER2011 — 2013Vienna, Austria
- Janssen, Pharmaceutical Companies of Johnson and JohnsonVICE PRESIDENT Licensing and New Business Development NEUROSCIENCES2008 — 2010Belgium/global role
- Janssen, Pharmaceutical Companies of Johnson and JohnsonVICE PRESIDENT Licensing, R&D Internal Medicine & Neurosciences2006 — 2008Beerse/ex-USA
- TibotecExecutive Director Scientific and Business Licensing VIROLOGY worldwide2004 — 2006Belgium/global
- Janssen, Pharmaceutical Companies of Johnson and JohnsonDirector TECHNOLOGY LICENSING2002 — 2004Belgium/Global
- Janssen, Pharmaceutical Companies of Johnson and JohnsonR&D Group leader, Principal scientist Gastrointestinal Emerging Diseases2002Belgium
- Janssen, Pharmaceutical Companies of Johnson and JohnsonR&D Group leader (US based team), Senior scientist IMMUNOLOGY2000 — 2002San Diego, USA
- Janssen, Pharmaceutical Companies of Johnson and JohnsonProject leader, Senior scientist Advanced BioTechnologies1996 — 1999Belgium
- Janssen, Pharmaceutical Companies of Johnson and JohnsonScientist, Experimental Molecular Biology1995 — 1996Belgium
Skills & more
HealthcarePharmaceutical IndustryLife SciencesGrowth StrategiesTurnaround ExperienceDrug DiscoveryInfectious DiseasesBiotechnologyClinical DevelopmentBusiness DevelopmentWIB Boardroom-ready trainedSales & Marketing
+2 more
ManagementVenture CapitalLanguages Dutch · English · French · German
From Marianne's professional profile.
Frequently asked questions
- Who is Marianne De Backer?
- CEO at Vir
- Where does Marianne De Backer work?
- Marianne De Backer is CEO at Vir.
- Where did Marianne De Backer go to school?
- Marianne De Backer studied at Ghent University (PhD in Biotechnology); Rotterdam School of Management, Erasmus University (Master of Business Administration - MBA); Harvard Business School (Private Equity and Venture Capital).
Same school
Also attended Ghent University174
Sabine VermassenExecutive Director at Capricorn Venture PartnersNoé WachsmuthVisiting Analyst at Capricorn Venture PartnersJeroen Van IseghemInvestment Analyst at Capricorn Venture PartnersLukasPartner at Hummingbird VenturesRoxanneCompliance Officer at Hummingbird VenturesGeoffrey D'hondtInvestment Director at Heran Partners
+ 168 more
Also attended Rotterdam School of Management, Erasmus University281
Julian LuttermanInvestor at DN CapitalWouterHead of Nomads (Fund-of-Fund) at Hummingbird VenturesAlexander RibbinkGeneral Partner at Keen Venture PartnersConrad SchooInvestor at EQT VenturesNoah FreyFinance Analyst at Emerald Technology Ventures AgJeroen PlinkVenture Partner at LegalTech
+ 275 more
Also attended The George Washington University382
RustyAdvisor at Clear VenturesDonna HoyleVice President & Controller at RevolutionMathew KayeAccounting Manager at RevolutionMeghan FahyDirector of Marketing at GreycroftMaurice RussoInvestor at Lerer HippeauZach CollinsPartner at Mission Biocapital
+ 376 more
Also attended New York University School of Law159
Sallie KimInvestor at 8VCSean TraynorPartner, Legal at Lux CapitalEsther DominguezGeneral Counsel at .406 VenturesLindsay MontiGeneral Counsel and CCO at JMI EquityMichael HsuVenture Partner at Core Venture CapitalSteve SwerdlowSenior Advisor at Navitas Capital
+ 153 more
Shared employers
Also worked at Vir Biotechnology, Inc.5
Also worked at Arrowhead Pharmaceuticals5
Also worked at EcoHealth Alliance3
Also worked at Johnson & Johnson361
Teresa ChanChief Financial Officer at Felicis VenturesKarthik ArdhanareeswaranInvestor at GV (Google Ventures)KobeFinance Director at Hummingbird VenturesMickelFinance & Risk Management at Hummingbird VenturesHal PazInvestor at Khosla VenturesNiall O'DonnellManaging Director at RiverVest Venture Partners
+ 355 more